These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38688943)

  • 21. CRISPR technologies and the search for the PAM-free nuclease.
    Collias D; Beisel CL
    Nat Commun; 2021 Jan; 12(1):555. PubMed ID: 33483498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a.
    Olivi L; Bagchus C; Pool V; Bekkering E; Speckner K; Offerhaus H; Wu WY; Depken M; Martens KJA; Staals RHJ; Hohlbein J
    Nucleic Acids Res; 2024 May; 52(9):5241-5256. PubMed ID: 38647045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
    Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
    Goldberg GW; Spencer JM; Giganti DO; Camellato BR; Agmon N; Ichikawa DM; Boeke JD; Noyes MB
    Nat Commun; 2021 Jan; 12(1):349. PubMed ID: 33441553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
    Mekler V; Kuznedelov K; Severinov K
    J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programming PAM antennae for efficient CRISPR-Cas9 DNA editing.
    Wang F; Hao Y; Li Q; Li J; Zhang H; Zhang X; Wang L; Bustamante C; Fan C
    Sci Adv; 2020 May; 6(19):eaay9948. PubMed ID: 32494703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
    Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
    Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
    Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
    Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.
    Mekler V; Minakhin L; Severinov K
    Proc Natl Acad Sci U S A; 2017 May; 114(21):5443-5448. PubMed ID: 28484024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.
    Hirano S; Nishimasu H; Ishitani R; Nureki O
    Mol Cell; 2016 Mar; 61(6):886-94. PubMed ID: 26990991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance.
    Babu K; Amrani N; Jiang W; Yogesha SD; Nguyen R; Qin PZ; Rajan R
    Biochemistry; 2019 Apr; 58(14):1905-1917. PubMed ID: 30916546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.
    Kang M; Zuo Z; Yin Z; Gu J
    J Chem Inf Model; 2022 Jun; 62(12):3057-3066. PubMed ID: 35666156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pipeline for characterization of novel Cas9 orthologs.
    Karvelis T; Young JK; Siksnys V
    Methods Enzymol; 2019; 616():219-240. PubMed ID: 30691644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.
    Acharya S; Ansari AH; Kumar Das P; Hirano S; Aich M; Rauthan R; Mahato S; Maddileti S; Sarkar S; Kumar M; Phutela R; Gulati S; Rahman A; Goel A; Afzal C; Paul D; Agrawal T; Pulimamidi VK; Jalali S; Nishimasu H; Mariappan I; Nureki O; Maiti S; Chakraborty D
    Nat Commun; 2024 Jun; 15(1):5471. PubMed ID: 38942756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
    Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
    Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
    Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
    Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
    Shou J; Li J; Liu Y; Wu Q
    Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9.
    Tsui TKM; Hand TH; Duboy EC; Li H
    ACS Synth Biol; 2017 Jun; 6(6):1103-1113. PubMed ID: 28277645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAM-Less CRISPR-SpRY Genome Editing in Plants.
    Sretenovic S; Tang X; Ren Q; Zhang Y; Qi Y
    Methods Mol Biol; 2023; 2653():3-19. PubMed ID: 36995616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.